Does the media refer more to BAX or AMN?

In the previous week, Baxter International had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 19 mentions for Baxter International and 5 mentions for AMN Healthcare Services. Baxter International's average media sentiment score of 0.15 beat AMN Healthcare Services' score of 0.08 indicating that Baxter International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to BAX or DVA?

In the previous week, Baxter International had 12 more articles in the media than DaVita. MarketBeat recorded 19 mentions for Baxter International and 7 mentions for DaVita. DaVita's average media sentiment score of 0.61 beat Baxter International's score of 0.15 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DaVita 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BAX or IDXX?

In the previous week, Baxter International and Baxter International both had 19 articles in the media. IDEXX Laboratories' average media sentiment score of 1.27 beat Baxter International's score of 0.15 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IDEXX Laboratories 15 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor RMD or BAX?

In the previous week, Baxter International had 3 more articles in the media than ResMed. MarketBeat recorded 19 mentions for Baxter International and 16 mentions for ResMed. ResMed's average media sentiment score of 0.99 beat Baxter International's score of 0.15 indicating that ResMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ResMed 11 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Baxter International (BAX) Competitors

$22.12 -0.50 (-2.19%)

Closing price 07/20/2026 03:59 PM Eastern

Extended Trading

$22.13 +0.02 (+0.07%)

As of 04:27 AM Eastern

Compare

BAX vs. AMN, DVA, IDXX, BDX, and RMD

Should you buy Baxter International stock or one of its competitors? MarketBeat compares Baxter International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Baxter International include AMN Healthcare Services (AMN), DaVita (DVA), IDEXX Laboratories (IDXX), Becton, Dickinson and Company (BDX), and ResMed (RMD). These companies are all part of the "medical" sector.

How does Baxter International compare to AMN Healthcare Services?

Baxter International (NYSE:BAX) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

AMN Healthcare Services has lower revenue, but higher earnings than Baxter International. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.02	-$957M	-$2.13	N/A
AMN Healthcare Services	$2.73B	0.48	-$95.70M	-$0.87	N/A

In the previous week, Baxter International had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 19 mentions for Baxter International and 5 mentions for AMN Healthcare Services. Baxter International's average media sentiment score of 0.15 beat AMN Healthcare Services' score of 0.08 indicating that Baxter International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

AMN Healthcare Services has a net margin of -0.95% compared to Baxter International's net margin of -9.70%. AMN Healthcare Services' return on equity of 18.01% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
AMN Healthcare Services	-0.95%	18.01%	5.19%

Baxter International has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market.

Baxter International currently has a consensus target price of $19.91, indicating a potential downside of 9.97%. AMN Healthcare Services has a consensus target price of $27.00, indicating a potential downside of 19.93%. Given Baxter International's higher possible upside, analysts plainly believe Baxter International is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	4 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.85
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Baxter International and AMN Healthcare Services tied by winning 8 of the 16 factors compared between the two stocks.

How does Baxter International compare to DaVita?

Baxter International (NYSE:BAX) and DaVita (NYSE:DVA) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

DaVita has a net margin of 5.65% compared to Baxter International's net margin of -9.70%. Baxter International's return on equity of 16.15% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
DaVita	5.65%	-270.37%	4.87%

Baxter International has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, DaVita has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 1.9% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Baxter International had 12 more articles in the media than DaVita. MarketBeat recorded 19 mentions for Baxter International and 7 mentions for DaVita. DaVita's average media sentiment score of 0.61 beat Baxter International's score of 0.15 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DaVita	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baxter International currently has a consensus target price of $19.91, indicating a potential downside of 9.97%. DaVita has a consensus target price of $216.50, indicating a potential downside of 7.54%. Given DaVita's stronger consensus rating and higher possible upside, analysts clearly believe DaVita is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	4 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.85
DaVita	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13

DaVita has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.02	-$957M	-$2.13	N/A
DaVita	$13.64B	1.10	$746.80M	$10.78	21.72

Summary

DaVita beats Baxter International on 11 of the 15 factors compared between the two stocks.

How does Baxter International compare to IDEXX Laboratories?

Baxter International (NYSE:BAX) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Baxter International has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market.

Baxter International currently has a consensus price target of $19.91, indicating a potential downside of 9.97%. IDEXX Laboratories has a consensus price target of $751.00, indicating a potential upside of 33.20%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe IDEXX Laboratories is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	4 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.85
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

90.2% of Baxter International shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 0.2% of Baxter International shares are held by insiders. Comparatively, 0.8% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Baxter International and Baxter International both had 19 articles in the media. IDEXX Laboratories' average media sentiment score of 1.27 beat Baxter International's score of 0.15 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IDEXX Laboratories	15 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.02	-$957M	-$2.13	N/A
IDEXX Laboratories	$4.30B	10.33	$1.06B	$13.58	41.52

IDEXX Laboratories has a net margin of 24.63% compared to Baxter International's net margin of -9.70%. IDEXX Laboratories' return on equity of 70.87% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
IDEXX Laboratories	24.63%	70.87%	32.56%

Summary

IDEXX Laboratories beats Baxter International on 13 of the 15 factors compared between the two stocks.

How does Baxter International compare to Becton, Dickinson and Company?

Baxter International (NYSE:BAX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.7%. Baxter International pays out -1.9% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Baxter International had 4 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 19 mentions for Baxter International and 15 mentions for Becton, Dickinson and Company. Becton, Dickinson and Company's average media sentiment score of 1.45 beat Baxter International's score of 0.15 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Becton, Dickinson and Company	12 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.02	-$957M	-$2.13	N/A
Becton, Dickinson and Company	$21.84B	1.95	$1.68B	$3.95	39.10

Baxter International has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

Baxter International currently has a consensus target price of $19.91, indicating a potential downside of 9.97%. Becton, Dickinson and Company has a consensus target price of $180.29, indicating a potential upside of 16.72%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts clearly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	4 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.85
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

Becton, Dickinson and Company has a net margin of 5.33% compared to Baxter International's net margin of -9.70%. Baxter International's return on equity of 16.15% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

Summary

Becton, Dickinson and Company beats Baxter International on 14 of the 19 factors compared between the two stocks.

How does Baxter International compare to ResMed?

ResMed (NYSE:RMD) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends.

ResMed has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ResMed	$5.15B	5.60	$1.40B	$10.37	19.15
Baxter International	$11.24B	1.02	-$957M	-$2.13	N/A

In the previous week, Baxter International had 3 more articles in the media than ResMed. MarketBeat recorded 19 mentions for Baxter International and 16 mentions for ResMed. ResMed's average media sentiment score of 0.99 beat Baxter International's score of 0.15 indicating that ResMed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ResMed	11 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

ResMed currently has a consensus price target of $250.00, indicating a potential upside of 25.91%. Baxter International has a consensus price target of $19.91, indicating a potential downside of 9.97%. Given ResMed's stronger consensus rating and higher probable upside, equities analysts plainly believe ResMed is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ResMed	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.53
Baxter International	4 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.85

ResMed pays an annual dividend of $2.40 per share and has a dividend yield of 1.2%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. ResMed pays out 23.1% of its earnings in the form of a dividend. Baxter International pays out -1.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. ResMed has raised its dividend for 13 consecutive years. ResMed is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

ResMed has a net margin of 27.44% compared to Baxter International's net margin of -9.70%. ResMed's return on equity of 25.35% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ResMed	27.44%	25.35%	18.69%
Baxter International	-9.70%	16.15%	5.24%

55.0% of ResMed shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 0.7% of ResMed shares are held by company insiders. Comparatively, 0.2% of Baxter International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

ResMed has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

Summary

ResMed beats Baxter International on 16 of the 20 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BAX vs. The Competition

Export

Metric	Baxter International	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$11.68B	$8.90B	$6.89B	$23.42B
Dividend Yield	0.18%	2.48%	2.67%	4.15%
P/E Ratio	-10.38	16.04	27.07	30.65
Price / Sales	1.02	6.77	515.45	20.33
Price / Cash	3.98	18.55	26.68	18.81
Price / Book	1.86	3.26	10.42	4.74
Net Income	-$957M	$230.22M	$3.60B	$1.07B
7 Day Performance	1.46%	-1.77%	-1.26%	-0.42%
1 Month Performance	11.01%	-1.97%	1.07%	0.69%
1 Year Performance	-19.30%	-0.92%	23.61%	16.45%

Baxter International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BAX Baxter International	1.4304 of 5 stars	$22.12 -2.2%	$19.91 -10.0%	-20.4%	$11.68B	$11.24B	N/A	37,500
AMN AMN Healthcare Services	1.5584 of 5 stars	$33.97 +4.9%	$27.00 -20.5%	+70.0%	$1.26B	$2.73B	N/A	2,664	Analyst Revision
DVA DaVita	3.6046 of 5 stars	$235.52 +1.2%	$209.00 -11.3%	+65.9%	$14.95B	$13.64B	21.85	78,000
IDXX IDEXX Laboratories	4.3381 of 5 stars	$564.21 +0.1%	$751.00 +33.1%	+9.6%	$44.46B	$4.30B	41.55	11,000	News Coverage
BDX Becton, Dickinson and Company	4.4092 of 5 stars	$153.88 +1.3%	$180.29 +17.2%	-13.6%	$41.87B	$21.84B	38.96	72,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BAX) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, IDXX, BDX, and RMD

How does Baxter International compare to AMN Healthcare Services?

Summary

How does Baxter International compare to DaVita?

Summary

How does Baxter International compare to IDEXX Laboratories?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Summary

How does Baxter International compare to ResMed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, IDXX, BDX, and RMD

How does Baxter International compare to AMN Healthcare Services?

Which has preferable valuation and earnings, BAX or AMN?

Does the media refer more to BAX or AMN?

Is BAX or AMN more profitable?

Which has more volatility & risk, BAX or AMN?

Do analysts prefer BAX or AMN?

Do insiders & institutionals have more ownership in BAX or AMN?

Summary

How does Baxter International compare to DaVita?

Is BAX or DVA more profitable?

Which has more volatility and risk, BAX or DVA?

Do institutionals & insiders have more ownership in BAX or DVA?

Does the media refer more to BAX or DVA?

Do analysts prefer BAX or DVA?

Which has better valuation & earnings, BAX or DVA?

Summary

How does Baxter International compare to IDEXX Laboratories?

Which has more volatility & risk, BAX or IDXX?

Do analysts recommend BAX or IDXX?

Do insiders and institutionals have more ownership in BAX or IDXX?

Does the media refer more to BAX or IDXX?

Which has preferable earnings & valuation, BAX or IDXX?

Is BAX or IDXX more profitable?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Is BAX or BDX a better dividend stock?

Does the media favor BAX or BDX?

Do insiders and institutionals hold more shares of BAX or BDX?

Which has higher earnings & valuation, BAX or BDX?

Which has more volatility & risk, BAX or BDX?

Do analysts prefer BAX or BDX?

Is BAX or BDX more profitable?

Summary

How does Baxter International compare to ResMed?

Which has stronger valuation and earnings, RMD or BAX?

Does the media favor RMD or BAX?

Do analysts recommend RMD or BAX?

Is RMD or BAX a better dividend stock?

Is RMD or BAX more profitable?

Do institutionals and insiders believe in RMD or BAX?

Which has more risk & volatility, RMD or BAX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools